The Global Dialysis Market size was valued to USD 105. 58 billion in 2021, and is predicted to garner USD 145. 85 billion by 2030, with a CAGR of 3. 6% from 2022-2030. Dialysis is a renal replacement therapy where excess water, salts, solutes, and toxins are removed from the blood of the patients whose kidneys do not perform these functions naturally.

New York, May 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2022 – 2030" - https://www.reportlinker.com/p06272302/?utm_source=GNW This is a blood purification procedure where toxins and excess fluids are removed from the body, thereby restoring the electrolyte balance of the blood. Dialysis holds wide applications in treatment of chronic kidney diseases, acute renal injury, for those expecting a kidney transplant, or as a permanent measure where a transplant is not advisable. There are two types of dialysis such as Hemodialysis and Peritoneal Dialysis. Hemodialysis includes extra-corporeal purification of blood, whereas Peritoneal Dialysis includes blood purification by using peritoneum in the patient’s abdomen for dialysis. Market Dynamics and Trends According to the National Kidney Foundation, 10% of the global population is affected by chronic kidney diseases; of which more than a million die each year due to lack of affordable treatments. This scenario has increased the penetration of dialysis treatment over the years, thereby supplementing the growth of the global dialysis market. Additionally, increase in funding for better dialysis products and services, as well as growing number of patients suffering from end-stage renal disease (ESRD), further propagates the growth of dialysis market. The increasing prevalence of diabetes that initially affects kidney functioning is likely to positively impact the dialysis market size throughout the forecast period. However, risks & complications associated with dialysis, and product recall may limit the growth of the dialysis market. Furthermore, rising incidences of kidney failures, lack of kidney donors for transplantations, tedious kidney transplant procedures, and increasing demand for home peritoneal dialysis treatment shall create new opportunities for the growth of global dialysis market in the future. Market Segmentations and Scope of the Study: The dialysis market share has been analyzed based on dialysis type, products & services, end user, and geography. Based on type, the dialysis market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Based on products & services, the market covers equipment, consumables, drugs, and services. The equipment segment is further divided into dialysis machines, water treatment systems, and others. The consumables segment is further distributed as dialyzers, catheters, and others. Based on the end user, the dialysis market is classified into in-center dialysis and home dialysis. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW. Geographical Analysis North America is expected to dominate the global dialysis market throughout the forecast period, accounting for the highest market share. This is attributed to factors such as presence of a hefty number of patients suffering from chronic kidney diseases in the U.S. & Canada, shortage of kidney donors, high consumer awareness, well-established health-care infrastructures, and advancements in medical technologies. Asia-Pacific region is expected to demonstrate a substantial growth rate, holding the highest CAGR values in the global dialysis market throughout the forecast period. Factors such as increased purchasing power of the patients, increasing prevalence pool of diabetes & hypertension, improving compensation scenario, as well as advancements in healthcare infrastructures and medical technologies, are propagating the growth of the global dialysis market. Competitive Landscape Comprehensive competitive analysis and profiles of the major market players such as Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others are provided in the dialysis market report. An upsurge in R&D activities and advancement in product technologies along with new product launches by the key players, is leading the healthcare infrastructure to new heights, thereby creating lucrative opportunities in the global dialysis market. For instance, in April 2020, one of the key players of the global dialysis market, Fresenius Medical Care AG & Co., powered by its previously acquired NxStage Medical portfolio, announced the expansion of its home-dialysis service offerings in the company’s EMEA region (Europe, Middle-East and Africa). This expansion enables the company with a larger number of patients probing for at-home treatment as well as wider options for treatment methods. The ‘NxStage SystemOne’ by Fresenius Medical Care is an HHD system that is explicitly designed, easy- to-operate, and allows the patients to dialyze for shorter periods with more frequency than in traditional dialysis procedures offered in clinic. It not only offers complete comfort to the patients but it is also advantageous in achieving improved blood pressure control and faster recovery time, hence bringing better treatment results. Fresenius Medical Care, the pioneer provider of dialysis products & services, with its NxStage Medical portfolio aims at offering every individual in the need for dialysis, the right therapy, at the right time, in the right place. Furthermore, in May 2020, the very well-known player of the global dialysis market, DaVita Inc., launched a venture group the ‘DaVita Venture Group (DVG),’ to accelerate its efforts in developing and deploying innovative solutions designed to improve the health- care and life-quality for people suffering from kidney disease and related chronic conditions. The DaVita Venture Group aims to find new solutions in creating innovative, patient-centric care models that utilize the latest technology. With strategic partnerships, venture investment opportunities, and incubating transformative solutions, DVG plans at testing and bringing cutting-edge technologies to market, as well as including innovation in digital health, care delivery models, medical devices, and pharmaceuticals. KEY MARKET SEGMENTS: - Global Dialysis Market – By Dialysis Type - Hemodialysis - Short Daily Hemodialysis - Conventional Hemodialysis - Nocturnal Hemodialysis - Peritoneal Dialysis - Automated Peritoneal Dialysis (APD) - Continuous Ambulatory Peritoneal Dialysis (CAPD) - Global Dialysis Market – By Products & Services - Equipment - Dialysis Machines - Water Treatment Systems - Others - Consumables - Dialyzers - Catheters - Others - Dialysis Drugs - Services - Global Dialysis Market – By End User - In-center Dialysis - Home Dialysis - Global Dialysis Market – By Geography - North America - U.S. - Canada - Mexico - Europe - UK - Germany - Spain - France - Italy - Rest of Europe - Asia-Pacific - China - India - Japan - Australia - Rest of Asia-Pacific - RoW - Saudi Arabia - South Africa - Brazil - Remaining Countries Read the full report: https://www.reportlinker.com/p06272302/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.

Many Americans are surprised to see they have not prepared as well as they had hoped for retirement when they finally get ready to call it quits. The bad news is, you’ll probably have to make some realistic assumptions of what your retirement will look like. If you’ve lived primarily paycheck to paycheck in your working years, that may continue to feel the case in your retirement.

When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.

The stocks for companies developing cancer therapies were moving in morning trading on Friday as biotechs and researchers shared new clinical findings in advance of next week’s American Society of Clinical Oncology annual meeting. Arcellx Inc.’s (ACLX) stock jumped 11.9% after an abstract provided updated data for its CART-ddBCMA. SVB Securities analysts said in a note on Friday that they were pleased to see that the experimental therapy “continues to have a competitive efficacy signal in 24 evaluable relapsed/refractory patients.”

Billions of dollars have been poured into companies seeking early detection of cancer through common blood draws.

(Bloomberg) -- Fertilizer prices that had hit records are now plunging as buyers reel from sticker shock, but that doesn’t mean the market squeeze is over. Most Read from BloombergRussian Wins in Eastern Ukraine Spark Debate Over Course of WarElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionFord Beats Tesla to the Punch With First Electric F-150 DeliveryZilingo’s Fired CEO Responds to Questions of Mystery PaymentsBitcoin Breaks From Stocks and Keeps On Falling as Crypto S

Tesla won't set up a manufacturing plant in India until it is first allowed to sell and service imported cars in the South Asian nation, the carmaker's chief executive Elon Musk said Friday, more than a year after an Indian state said that the electric carmaker was planning to open a plant in the southern part of the country. Responding to an individual on Twitter, who had asked for an update on Tesla's manufacturing plant in India, Musk responded, "Tesla will not put a manufacturing plant in any location where we are not allowed first to sell & service cars."

Eli Lilly said Friday it will unveil new test results for its biggest cancer drug, Verzenio, in June and LLY stock broke out to a fresh high.

Global car production has been hampered for months because of a plethora of supply-chain and logistics issues. Friday, Toyota Motor (ticker: TM) cut its production plans again. Toyota is taking additional downtime at some plants the week of June 6.

Retirement savers are often told they’ll see a greater return in their retirement assets if they invest it – and that may be true – but it’s important to prioritize some cash in a retirement plan as well. Retirement Tip of the Week: For those close to retirement, consider keeping a portion of your retirement plan in cash – whether that be in the portfolio itself, or in a separate account. Bank and money market accounts do not generate the same type of returns as investments, though right now with volatility some investors may beg to differ.

While the price of gasoline frequently steals all the headlines, the price of diesel is actually more important when it comes to the cost of living and the economy.

The departure comes as the electric-truck startup is under pressure to overcome supply-chain problems that led the company to lower its production forecast for the year.

When Warren Buffett, the CEO of conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), buys or sells a stock, Wall Street and investors tend to pay close attention. Since taking the reins, Buffett has created close to $670 billion in value for his shareholders (which includes himself), and he's led his company's Class A shares (BRK.A) to an almost unfathomable 20.1% average annual return. To put this performance in another context, the benchmark S&P 500 has "only" gained 30,209%, including dividends paid, since Buffett took over Berkshire Hathaway.

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

As covid-19 has become less of a threat in recent months, companies have tried different ways to get people back to the office. It’s not enough to make people like the office—or even show up to it. JPMorgan’s Jamie Dimon—previously one of the CEOs most insistent on return to the office—said in a May investor letter (pdf) that 40% of the bank’s staff would likely mix office time with home working from now on, and another 10% “in very specific roles” will likely work from home full time.

The pharma giant's drug combo is now just months away from potential U.S. approval for a type of liver cancer.

JPMorgan expects fewer iPhone 14 units to be built in 2022 than the previous iPhone 13 model built in 2021.

The highest paid CEOs in America in 2021, according to Fortune's new analysis of executive pay.